Indications and Usage:
Liquid E-Z-PAQUE (barium sulfate) oral suspension (60% w/v) is indicated for use in single contrast radiographic examinations of the esophagus, stomach, and small bowel to visualize the gastrointestinal (GI) tract in adult and pediatric patients.
IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known gastric or intestinal perforation, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents.
Please see full Prescribing Information for Liquid E-Z-PAQUE (barium sulfate) oral suspension (60% w/v) by clicking here.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Liquid E-Z-PAQUE is manufactured by E-Z-EM Canada Inc., for E-Z-EM, Inc., a subsidiary of Bracco Diagnostics Inc., Monroe Twp., NJ 08831.
E-Z-PAQUE is a registered trademark of E-Z-EM, Inc.